We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Diurnal Group Plc | LSE:DNL | London | Ordinary Share | GB00BDB6Q760 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.30 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
23/12/2020 13:21 | There are many many people watching this on the sidelines, you can now be sure looking at the chart that we have finally bottomed out. I suspect 15th Jan onwards we will be 65p upwards | aimmafia | |
23/12/2020 12:33 | Buyers appear to be returning, taken a while. Hopefully the large seller has finished. | mufprat | |
23/12/2020 12:28 | It's not a spike. It's re rating... we shouldn't be down here in the first place. Next stop is 65p | aimmafia | |
23/12/2020 11:37 | interesting? | royalalbert | |
23/12/2020 11:33 | nice little spike | qs99 | |
23/12/2020 11:33 | Only four AIM companies with FDA approval I think, we will come good. | royalalbert | |
23/12/2020 11:30 | Really think the FDA approval and link up with Eton has been overlooked, also milestone payment from Eton due? POLX proving today the FDA process works to its own timetable. Hopefully rerate will commence 2021. | yasrub | |
23/12/2020 10:30 | I forgot the markets were open today. Nice to see us up. A nice wedge forming at the bottom now so really hope we can push on and maintain the upwards trend. Merry Xmas all. I hope not too many people in tier 4 like myself! | aimmafia | |
22/12/2020 20:53 | Lol........... | tialouise | |
22/12/2020 19:02 | More dilution | aimmafia | |
22/12/2020 17:24 | The performance related conditions to these grants are a breath of fresh air most Aim companies issue share options to Under performing management I’m very comfortable. I will be extremely pleased if the grants become awarded as my reward will be extremely rewarding | best1467 | |
22/12/2020 16:52 | more like disgusted! give yourself 1m options for just doing the job your paid to do | jusjusjus | |
21/12/2020 17:01 | Some impatient sells at the bell - | aimmafia | |
21/12/2020 15:27 | At the end of the day this company will bounce back. I dont buy for a weeks trade.Still loads of news due. | aimmafia | |
21/12/2020 14:48 | do any of you listen to the news? european mkts are heavily down because we the brits are being blamed for CHINA VIRUS NO2! | abbynat | |
21/12/2020 14:35 | If it wasn't for the discounted placing this share would not be sitting at such low levels.It was trading at 70p on Alkindi approval by FDA only a month back. It is now 30% down from that level. | glasswala | |
21/12/2020 12:42 | For the benefit of myself and the others on the board could you explain what nice buying is ? In particular with reference to the fact that I am looking a page full of sells today ? Lol. Crabs | scrabster1 | |
18/12/2020 09:44 | So every nice buying this morning. News looming? There surely has to be some news soon. | aimmafia | |
18/12/2020 08:55 | It's bounced of 48 3 times now. I suspect we have finally bounced off the bottom | aimmafia | |
18/12/2020 08:54 | Looks like a good end to the week TT | tburns | |
18/12/2020 08:29 | Nice to see buyers moving in | trotterstrading | |
17/12/2020 17:09 | A bit more positive today, although the share price seems depressed at the moment we are still in an upward trend. | aimmafia | |
17/12/2020 13:39 | Have been in contact with the Board to express my displeasure regarding the placing and lack of support afterwards.Always a risk to participate in a fund raise but certainly wasn't expecting a 20% sell off from the placing price. | mufprat |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions